Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Covington
McKinsey
Healthtrust
Baxter

Generated: April 20, 2019

DrugPatentWatch Database Preview

Leadiant Biosci Inc Company Profile

« Back to Dashboard

What is the competitive landscape for LEADIANT BIOSCI INC, and when can generic versions of LEADIANT BIOSCI INC drugs launch?

LEADIANT BIOSCI INC has eight approved drugs.

There are four US patents protecting LEADIANT BIOSCI INC drugs.

There are fifty patent family members on LEADIANT BIOSCI INC drugs in twenty-four countries and three supplementary protection certificates in two countries.

Summary for Leadiant Biosci Inc
International Patents:50
US Patents:4
Tradenames:7
Ingredients:6
NDAs:8

Drugs and US Patents for Leadiant Biosci Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leadiant Biosci Inc CARNITOR levocarnitine TABLET;ORAL 018948-001 Dec 27, 1985 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes 6,429,230 ➤ Sign Up ➤ Sign Up
Leadiant Biosci Inc CHENIX chenodiol TABLET;ORAL 018513-002 Jul 28, 1983 DISCN Yes No ➤ Sign Up ➤ Sign Up
Leadiant Biosci Inc MATULANE procarbazine hydrochloride CAPSULE;ORAL 016785-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up
Leadiant Biosci Inc ADAGEN pegademase bovine INJECTABLE;INJECTION 019818-001 Mar 21, 1990 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for Leadiant Biosci Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leadiant Biosci Inc ADAGEN pegademase bovine INJECTABLE;INJECTION 019818-001 Mar 21, 1990 4,179,337 ➤ Sign Up
Leadiant Biosci Inc MATULANE procarbazine hydrochloride CAPSULE;ORAL 016785-001 Approved Prior to Jan 1, 1982 3,520,926 ➤ Sign Up
Leadiant Biosci Inc ABELCET amphotericin b INJECTABLE, LIPID COMPLEX;INJECTION 050724-001 Nov 20, 1995 5,616,334 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Leadiant Biosci Inc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1919458 C300649 Netherlands ➤ Sign Up PRODUCT NAME: CYSTEAMINE; REGISTRATION NO/DATE: EU/1/13/861/001-002 20130906
1919458 2014C/018 Belgium ➤ Sign Up PRODUCT NAME: CYSTEAMINE; AUTHORISATION NUMBER AND DATE: EU/1/13/861 20130910
1919458 300649 Netherlands ➤ Sign Up PRODUCT NAME: CYSTEAMINE; REGISTRATION NO/DATE: EU/1/13/861/001-002 20130910
Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Farmers Insurance
Fish and Richardson
Fuji
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.